Keywords: anadys, nominates, ana598, development, pharmaceuticals, biopharmaceutical, company

Anadys nominates ANA598 for development

Article | 25 June 2007

Anadys Pharmaceuticals, a US biopharmaceutical company focused on developing novel medicines for the treatment of hepatitis and cancer, says that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Nystatin

Go to drug listing